Nofouzi Katayoon, Shakeri Setareh, Nikkhah Shadi, Hosseini Reza H, Khordadmehr Monireh, Madadi MohammadSadegh, Khamnei Hossein Jabbari, Bakhtiari Naghmeh Moori
Department of Pathobiology, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.
Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.
BMC Microbiol. 2025 Aug 18;25(1):518. doi: 10.1186/s12866-025-04263-2.
Gallibacterium anatis (G. anatis), a microorganism of the Pasteurellaceae family, is an emerging avian pathogen associated with reproductive and respiratory diseases in poultry. However, its role in ornamental birds is still poorly understood. The aim of the present study was to conduct the first comprehensive survey of the prevalence of G. anatis in pet birds, to investigate its antimicrobial resistance (AMR) profile and to assess its ability to form biofilms using cultural, biochemical, molecular and histopathological methods.
In this study, 191 fecal and tissue samples were collected from various companion birds. Clinical samples were cultured on 5% sheep blood agar and MacConkey agar plates to isolate bacterial pathogens. After incubation, colonies were evaluated based on their macroscopic characteristics such as size, color, and hemolytic properties on blood agar-and a Gram stain was performed as an essential preliminary step for bacterial identification. The 16-23 S rRNA gene region of G. anatis was amplified by PCR method. The disc diffusion method was used to assess microbial susceptibility and resistance. Biofilm formation was analyzed using a microtiter plate assay. Tissue samples were routinely processed, embedded in paraffin, sectioned and stained with common haematoxylin-eosin (H&E).
In this study, 20 G. anatis strains were isolated from 191 clinical samples of pet birds, representing a prevalence of 10.5%. Isolates were identified by colony morphology, Gram staining, biochemical testing and PCR for the -intergenic spacer region of 16-23 S rRNA, which yielded diagnostic amplicons of 790 bp and 1080 bp. Antimicrobial susceptibility testing showed complete susceptibility to ciprofloxacin (100%) and remarkable resistance to erythromycin (80%). β-lactam resistance was prevalent, with 70% and 75% of isolates resistant to ampicillin and amoxicillin, respectively. Biofilm formation tests showed that 80% of isolates had moderate biofilm formation. Gross and histopathological examinations of infected birds revealed severe respiratory and systemic lesions, including tracheitis, bronchopneumonia with focal necrosis, multifocal hepatic necrosis, and vascular congestion in multiple organs.
These results support the idea that G. anatis is a potentially important pathogen, with a biofilm-forming ability that contributes to treatment failure and environmental persistence. The 45% prevalence of multidrug resistance (MDR) highlights the pressing need for antimicrobial stewardship in avian veterinary medicine. Given the zoonotic potential of G. anatis, our study underscores the importance of One Health surveillance efforts in mitigating risk to both poultry and humans.
鸭疫里默氏杆菌(G. anatis)是巴氏杆菌科的一种微生物,是一种新出现的与家禽生殖和呼吸道疾病相关的禽类病原体。然而,其在观赏鸟中的作用仍知之甚少。本研究的目的是首次全面调查宠物鸟中鸭疫里默氏杆菌的流行情况,调查其抗菌药物耐药性(AMR)概况,并使用培养、生化、分子和组织病理学方法评估其形成生物膜的能力。
在本研究中,从各种伴侣鸟中收集了191份粪便和组织样本。临床样本在5%羊血琼脂和麦康凯琼脂平板上培养以分离细菌病原体。培养后,根据菌落的宏观特征如大小、颜色和在血琼脂上的溶血特性对菌落进行评估,并进行革兰氏染色作为细菌鉴定的重要初步步骤。通过PCR方法扩增鸭疫里默氏杆菌的16 - 23 S rRNA基因区域。采用纸片扩散法评估微生物的敏感性和耐药性。使用微量滴定板试验分析生物膜形成。组织样本常规处理,石蜡包埋,切片并用普通苏木精 - 伊红(H&E)染色。
在本研究中,从191份宠物鸟临床样本中分离出20株鸭疫里默氏杆菌菌株,患病率为10.5%。通过菌落形态、革兰氏染色、生化试验以及针对16 - 23 S rRNA基因间隔区的PCR对分离株进行鉴定,产生了790 bp和1080 bp的诊断性扩增子。抗菌药物敏感性测试显示对环丙沙星完全敏感(100%),对红霉素耐药性显著(80%)。β - 内酰胺类耐药普遍,分别有70%和75%的分离株对氨苄西林和阿莫西林耐药。生物膜形成试验表明80%的分离株具有中度生物膜形成能力。对感染鸟类的大体和组织病理学检查显示严重的呼吸道和全身病变,包括气管炎、伴有局灶性坏死的支气管肺炎、多灶性肝坏死以及多个器官的血管充血。
这些结果支持了鸭疫里默氏杆菌是一种潜在重要病原体的观点,其形成生物膜的能力导致治疗失败和在环境中持续存在。45%的多重耐药(MDR)患病率凸显了禽兽医抗菌药物管理的迫切需求。鉴于鸭疫里默氏杆菌的人畜共患病潜力,我们的研究强调了“同一健康”监测工作对于降低家禽和人类风险的重要性。